Furilazole; Pesticide Tolerances, 52771-52774 [2019-20874]
Download as PDF
Federal Register / Vol. 84, No. 192 / Thursday, October 3, 2019 / Rules and Regulations
PART 52—APPROVAL AND
PROMULGATION OF
IMPLEMENTATION PLANS
1. The authority citation for part 52
continues to read as follows:
■
Authority: 42 U.S.C. 7401 et seq.
Subpart D-Arizona
2. Section 52.131 is amended by
adding paragraph (d) to read as follows:
■
§ 52.131 Control Strategy and regulations:
Fine Particle Matter.
*
*
*
*
*
(d) Determination of attainment.
Effective November 4, 2019, the EPA
has determined that, based on 2015 to
2017 ambient air quality data, the West
Central Pinal County, AZ PM2.5
nonattainment area has attained the
2006 24-hour PM2.5 NAAQS by the
applicable attainment date of December
31, 2017. Therefore, the EPA has met
the requirement pursuant to CAA
section 188(b)(2) to determine whether
the area attained the standard. The EPA
also has determined that the West
Central Pinal County, AZ nonattainment
area will not be reclassified for failure
to attain by its applicable attainment
date under section 188(b)(2).
[FR Doc. 2019–21206 Filed 10–2–19; 8:45 am]
BILLING CODE 6560–50–P
ENVIRONMENTAL PROTECTION
AGENCY
40 CFR Part 180
[EPA–HQ–OPP–2018–0243; FRL–10000–23]
Furilazole; Pesticide Tolerances
Environmental Protection
Agency (EPA).
ACTION: Final rule.
AGENCY:
VerDate Sep<11>2014
16:33 Oct 02, 2019
Jkt 250001
I. General Information
A. Does this action apply to me?
You may be potentially affected by
this action if you are an agricultural
producer, food manufacturer, or
pesticide manufacturer. The following
list of North American Industrial
Classification System (NAICS) codes is
not intended to be exhaustive, but rather
provides a guide to help readers
determine whether this document
applies to them. Potentially affected
entities may include:
• Crop production (NAICS code 111).
• Animal production (NAICS code
112).
• Food manufacturing (NAICS code
311).
• Pesticide manufacturing (NAICS
code 32532).
B. How can I get electronic access to
other related information?
This regulation establishes
tolerances for residues of furilazole in or
on sweet corn commodities. The
Monsanto Company submitted a
petition to EPA under the Federal Food,
Drug, and Cosmetic Act (FFDCA)
requesting these tolerances.
DATES: This regulation is effective
October 3, 2019. Objections and
requests for hearings must be received
on or before December 2, 2019, and
must be filed in accordance with the
instructions provided in 40 CFR part
178 (see also Unit I.C. of the
SUPPLEMENTARY INFORMATION).
ADDRESSES: The docket for this action,
identified by docket identification (ID)
number EPA–HQ–OPP–2018–0243, is
available at https://www.regulations.gov
or at the Office of Pesticide Programs
SUMMARY:
Regulatory Public Docket (OPP Docket)
in the Environmental Protection Agency
Docket Center (EPA/DC), West William
Jefferson Clinton Bldg., Rm. 3334, 1301
Constitution Ave. NW, Washington, DC
20460–0001. The Public Reading Room
is open from 8:30 a.m. to 4:30 p.m.,
Monday through Friday, excluding legal
holidays. The telephone number for the
Public Reading Room is (202) 566–1744,
and the telephone number for the OPP
Docket is (703) 305–5805. Please review
the visitor instructions and additional
information about the docket available
at https://www.epa.gov/dockets.
FOR FURTHER INFORMATION CONTACT:
Michael Goodis, Registration Division
(7505P), Office of Pesticide Programs,
Environmental Protection Agency, 1200
Pennsylvania Ave. NW, Washington, DC
20460–0001; main telephone number:
(703) 305–7090; email address:
RDFRNotices@epa.gov.
SUPPLEMENTARY INFORMATION:
You may access a frequently updated
electronic version of EPA’s tolerance
regulations at 40 CFR part 180 through
the Government Publishing Office’s eCFR site at https://www.ecfr.gov/cgi-bin/
text-idx?&c=ecfr&tpl=/ecfrbrowse/
Title40/40tab_02.tpl.
C. How can I file an objection or hearing
request?
Under FFDCA section 408(g), 21
U.S.C. 346a, any person may file an
objection to any aspect of this regulation
and may also request a hearing on those
objections. You must file your objection
or request a hearing on this regulation
in accordance with the instructions
provided in 40 CFR part 178. To ensure
proper receipt by EPA, you must
identify docket ID number EPA–HQ–
PO 00000
Frm 00025
Fmt 4700
Sfmt 4700
52771
OPP–2018–0243 in the subject line on
the first page of your submission. All
objections and requests for a hearing
must be in writing, and must be
received by the Hearing Clerk on or
before December 2, 2019. Addresses for
mail and hand delivery of objections
and hearing requests are provided in 40
CFR 178.25(b).
In addition to filing an objection or
hearing request with the Hearing Clerk
as described in 40 CFR part 178, please
submit a copy of the filing (excluding
any Confidential Business Information
(CBI)) for inclusion in the public docket.
Information not marked confidential
pursuant to 40 CFR part 2 may be
disclosed publicly by EPA without prior
notice. Submit the non-CBI copy of your
objection or hearing request, identified
by docket ID number EPA–HQ–OPP–
2018–0243, by one of the following
methods:
• Federal eRulemaking Portal: https://
www.regulations.gov. Follow the online
instructions for submitting comments.
Do not submit electronically any
information you consider to be CBI or
other information whose disclosure is
restricted by statute.
• Mail: OPP Docket, Environmental
Protection Agency Docket Center (EPA/
DC), (28221T), 1200 Pennsylvania Ave.
NW, Washington, DC 20460–0001.
• Hand Delivery: To make special
arrangements for hand delivery or
delivery of boxed information, please
follow the instructions at https://
www.epa.gov/dockets/contacts.html.
Additional instructions on commenting
or visiting the docket, along with more
information about dockets generally, is
available at https://www.epa.gov/
dockets.
II. Summary of Petitioned-for Tolerance
In the Federal Register of October 18,
2018 (83 FR 52787) (FRL–9984–21),
EPA issued a document pursuant to
FFDCA section 408(d)(3), 21 U.S.C.
346a(d)(3), announcing the filing of a
pesticide petition (PP IN–11139) by
Monsanto, 1300 I Street NW,
Washington, DC 20005. The petition
requested that 40 CFR part 180 be
amended by establishing tolerances for
residues of furilazole when used as an
inert ingredient (safener) in pesticide
formulations applied to corn, sweet,
forage at 0.01 parts per million (ppm);
corn, sweet, kernel plus cob with husks
removed at 0.01 ppm; and corn, sweet,
stover at 0.01 ppm. That document
referenced a summary of the petition
prepared by Monsanto, the registrant,
which is available in the docket, https://
www.regulations.gov.
E:\FR\FM\03OCR1.SGM
03OCR1
52772
Federal Register / Vol. 84, No. 192 / Thursday, October 3, 2019 / Rules and Regulations
Based upon review of the data
supporting the petition, EPA is
establishing the tolerances as requested.
III. Aggregate Risk Assessment and
Determination of Safety
Section 408(b)(2)(A)(i) of FFDCA
allows EPA to establish a tolerance (the
legal limit for a pesticide chemical
residue in or on a food) only if EPA
determines that the tolerance is ‘‘safe.’’
Section 408(b)(2)(A)(ii) of FFDCA
defines ‘‘safe’’ to mean that ‘‘there is a
reasonable certainty that no harm will
result from aggregate exposure to the
pesticide chemical residue, including
all anticipated dietary exposures and all
other exposures for which there is
reliable information.’’ This includes
exposure through drinking water and in
residential settings but does not include
occupational exposure. Section
408(b)(2)(C) of FFDCA requires EPA to
give special consideration to exposure
of infants and children to the pesticide
chemical residue in establishing a
tolerance and to ‘‘ensure that there is a
reasonable certainty that no harm will
result to infants and children from
aggregate exposure to the pesticide
chemical residue. . . .’’
Consistent with FFDCA section
408(b)(2)(D), and the factors specified in
FFDCA section 408(b)(2)(D), EPA has
reviewed the available scientific data
and other relevant information in
support of this action. EPA has
sufficient data to assess the hazards of
and to make a determination on
aggregate exposure for furilazole
including exposure resulting from the
tolerances established by this action.
EPA’s assessment of exposures and risks
associated with furilazole follows.
A. Toxicological Profile
EPA has evaluated the available
toxicity data and considered their
validity, completeness, and reliability as
well as the relationship of the results of
the studies to human risk. EPA has also
considered available information
concerning the variability of the
sensitivities of major identifiable
subgroups of consumers, including
infants and children. The toxicological
profile of furilazole is discussed in the
final tolerance rule found in the Federal
Register of October 10, 2007 (72 FR
57489) (FRL–8145–2). Specific
information on the studies received and
the nature of the adverse effects caused
by furilazole as well as the no-observedadverse-effect-level (NOAEL) and the
lowest-observed-adverse-effect-level
(LOAEL) from the toxicity studies are
discussed in the final rule published in
Unit III.A. of that Federal Register
document and in the supporting
VerDate Sep<11>2014
16:33 Oct 02, 2019
Jkt 250001
documents for that rule. In addition,
due to the similarities between that rule
and this, EPA is incorporating the
findings concerning the children’s
safety factor and cumulative exposure
into this rule because they also apply to
this rulemaking. The summary of
toxicological endpoints the Agency used
to assess risk are discussed in the final
tolerance rule found in the Federal
Register of April 3, 2002 (67 FR 15727)
(FRL–6828–4).
B. Exposure Assessment
1. Dietary exposure (food and
drinking water). In evaluating dietary
exposure to furilazole, EPA considered
exposure under the proposed exemption
from the requirement of a tolerance as
well as the already established
tolerances for furilazole.
i. Acute exposure. Quantitative acute
dietary exposure and risk assessments
are performed for a food-use pesticide,
if a toxicological study has indicated the
possibility of an effect of concern
occurring as a result of a 1-day or single
exposure.
No such effects were identified in the
toxicological studies for the general
population for furilazole; therefore, a
quantitative acute dietary exposure
assessment for the general population is
unnecessary.
However, such effects were identified
for furilazole for females 13 to 50 years
old. In estimating acute dietary
exposure, EPA used 2003–2008 food
consumption information from the U.S.
Department of Agriculture’s National
Health and Nutrition Examination
Survey, What We Eat in America,
(NHANES/WWEIA). As to residue levels
in food, EPA conducted an unrefined
acute dietary exposure and risk
assessment assuming 100 percent crop
treated (PCT), default processing factors,
and tolerance-level residues for all food
commodities.
ii. Chronic exposure. In conducting
the chronic dietary exposure assessment
EPA used 2003–2008 food consumption
data from the USDA’s NHANES/
WWEIA. As to residue levels in food,
EPA conducted an unrefined chronic
dietary exposure and risk assessment
assuming 100 PCT, default processing
factors (when available), and tolerance
level residues for all food commodities.
iii. Cancer. As indicated in the 2002
Federal Register document, EPA has
concluded that furilazole should be
classified as a possible human
carcinogen and a linear approach has
been used the quantify cancer risk since
no mode of action data are available.
The aggregate cancer risk assessment for
adults takes into account exposure
estimates from dietary consumption of
PO 00000
Frm 00026
Fmt 4700
Sfmt 4700
furilazole from food and drinking water
sources. Dietary exposure assessments
were quantified using the same
estimates as discussed in Unit III.B.1.ii,
Chronic Exposure.
2. Dietary exposure from drinking
water. The Agency used screening level
water exposure models in the dietary
exposure analysis and risk assessment
for furilazole in drinking water. These
simulation models take into account
data on the physical, chemical, and fate/
transport characteristics of furilazole.
Further information regarding EPA
drinking water models used in pesticide
exposure assessment can be found at
https://www2.epa.gov/pesticide-scienceand-assessing-pesticide-risks/aboutwater-exposure-models-used-pesticide.
The estimated drinking water
concentrations (EDWCs) of furilazole for
acute exposures are estimated to be 1.2
parts per billion (ppb) for surface water
and 0.02 ppb for ground water; for
chronic exposures for non-cancer
assessments are estimated to be 0.8 ppb
for surface water and 0.02 ppb for
ground water; and for chronic exposures
for cancer assessments are estimated to
be 0.22 ppb for surface water and 0.02
ppb for ground water.
Modeled estimates of drinking water
concentrations were directly entered
into the dietary exposure model. For the
acute dietary risk assessment, a water
concentration value of 1.2 ppb was used
to assess the contribution to drinking
water, for the chronic dietary risk
assessment, the water concentration
value of 0.8 ppb was used to assess the
contribution to drinking water. For the
cancer dietary risk assessment, the
water concentration value of 0.22 ppb
was used to assess the contribution to
drinking water.
3. From non-dietary exposure. The
term ‘‘residential exposure’’ is used in
this document to refer to nonoccupational, non-dietary exposure
(e.g., textiles (clothing and diapers),
carpets, swimming pools, and hard
surface disinfection on walls, floors,
tables). There are no residential uses of
furilazole; therefore, a residential
exposure assessment was not
conducted.
4. Cumulative effects from substances
with a common mechanism of toxicity.
Section 408(b)(2)(D)(v) of FFDCA
requires that, when considering whether
to establish, modify, or revoke a
tolerance, the Agency consider
‘‘available information’’ concerning the
cumulative effects of a particular
pesticide’s residues and ‘‘other
substances that have a common
mechanism of toxicity.’’
Unlike other pesticides for which EPA
has followed a cumulative risk approach
E:\FR\FM\03OCR1.SGM
03OCR1
Federal Register / Vol. 84, No. 192 / Thursday, October 3, 2019 / Rules and Regulations
based on a common mechanism of
toxicity, EPA has not made a common
mechanism of toxicity finding as to
furilazole and any other substances;
furilazole does not appear to produce
any other toxic metabolite produced by
other substances. For the purposes of
this action, therefore, EPA has not
assumed that furilazole has a common
mechanism of toxicity with other
substances.
C. Aggregate Risks and Determination of
Safety
EPA determines whether acute and
chronic dietary pesticide exposures are
safe by comparing aggregate exposure
estimates to the acute PAD (aPAD) and
chronic PAD (cPAD). For linear cancer
risks, EPA calculates the lifetime
probability of acquiring cancer given the
estimated aggregate exposure. Short-,
intermediate-, and chronic-term risks
are evaluated by comparing the
estimated aggregate food, water, and
residential exposure to the appropriate
PODs to ensure that an adequate MOE
exists.
1. Acute risk. Using the exposure
assumptions discussed in this unit for
acute exposure, the acute dietary
exposure from food and water to
furilazole will be less than 1% for
females 13 to 49 years old, the only
population group of concern.
2. Chronic risk. Using the exposure
assumptions described in this unit for
chronic exposure, EPA has concluded
that chronic exposure to furilazole from
food and water will utilize 13.3% of the
cPAD for non-nursing infants, the
population group receiving the greatest
exposure. There are no expected
residential uses and therefore chronic
residential exposure to residues of
furilazole is not expected.
3. Short-term risk. Short-term
aggregate exposure takes into account
short-term residential exposure plus
chronic exposure to food and water
(considered to be a background
exposure level). Because there are no
proposed or registered residential uses
of furilazole a short-term assessment
was not performed. The chronic risk
assessment is protective for any shortterm exposures from food and drinking
water.
4. Intermediate-term risk.
Intermediate-term aggregate exposure
takes into account intermediate-term
residential exposure plus chronic
exposure to food and water (considered
to be a background exposure level).
Because there are no proposed or
registered residential uses of furilazole
an intermediate-term assessment was
not performed. The chronic risk
assessment is protective for any
VerDate Sep<11>2014
16:33 Oct 02, 2019
Jkt 250001
intermediate-term exposures from food
and drinking water. Furilazole is not
currently registered for uses that could
result in intermediate-term residential
exposure, and the Agency has
determined that intermediate-term
aggregate exposure assessment is not
necessary.
5. Aggregate cancer risk for U.S.
population. A cancer aggregate
assessment was conducted for furilazole
since it is classified as a ‘‘Group C,
Possible Human Carcinogen’’ with a Q1*
of 0.0274 (mg/kg/day)¥1 based upon
hepatocellular ademonas and
carcinomas in rats and mice,
branchioalveolar adenomas and
carcinomas in female mice, testicular
interstitial cell interstitial cell tumors in
male rats, and stomach tumors in female
mice. The cancer risk estimate for adults
is 1.1 × 10¥6.
EPA generally considers cancer risks
(expressed as the probability of an
increased cancer case) in the range of 1
in 1 million (or 1 × 10¥6) or less to be
negligible. The precision which can be
assumed for cancer risk estimates is best
described by rounding to the nearest
integral order of magnitude on the
logarithmic scale; for example, risks
falling between 3 × 10¥7 and 3 × 10¥6
are expressed as risks in the range of
10¥6. Considering the precision with
which cancer hazard can be estimated,
the conservativeness of low-dose linear
extrapolation, and the rounding
procedure described above, cancer risk
should generally not be assumed to
exceed the benchmark level of concern
of the range of 10¥6 until the calculated
risk exceeds approximately 3 × 10¥6.
This is particularly the case where some
conservatism is maintained in the
exposure assessment. EPA has
concluded the cancer risk for all
existing furilazole uses and the uses
associated with the tolerances
established in this action fall within the
range of 1 × 10¥6 and are thus
negligible.
EPA has concluded that using the
nonlinear approach based on the
chronic RfD will be protective of
potential carcinogenicity.
Because the chronic risk is below the
Agency’s level of concern, EPA
concludes there is no aggregate cancer
risk from exposure to furilazole.
6. Determination of safety. Taking
into consideration all available
information on furilazole, EPA has
determined that there is a reasonable
certainty that no harm to any population
subgroup will result from aggregate
exposure to furilazole.
PO 00000
Frm 00027
Fmt 4700
Sfmt 4700
52773
IV. Other Considerations
A. Analytical Enforcement Methodology
Adequate enforcement methodology
(capillary gas chromotography using
electron capture detection) is available
to enforce the tolerance exemption
expression. The method may be
requested from: Chief, Analytical
Chemistry Branch, Environmental
Science Center, 701 Mapes Rd., Ft.
Meade, MD 20755–5350; telephone
number: (410) 305–2905; email address:
residuemethods@epa.gov.
B. International Residue Limits
In making its tolerance decisions, EPA
seeks to harmonize U.S. tolerances with
international standards whenever
possible, consistent with U.S. food
safety standards and agricultural
practices. EPA considers the
international maximum residue limits
(MRLs) established by the Codex
Alimentarius Commission (Codex), as
required by FFDCA section 408(b)(4).
The Codex Alimentarius is a joint
United Nations Food and Agriculture
Organization/World Health
Organization food standards program,
and it is recognized as an international
food safety standards-setting
organization in trade agreements to
which the United States is a party. EPA
may establish a tolerance that is
different from a Codex MRL; however,
FFDCA section 408(b)(4) requires that
EPA explain the reasons for departing
from the Codex level. The Codex has not
established any MRLs for furilazole.
C. Response to Comments
Three comments were submitted to
the docket for this action. One dealt
with ‘‘relaxing’’ current EPA standards;
another argued that inert ingredients
should be regulated through tolerances.
A third comment took issue with data
submitted about the toxicity of
‘‘Florazole’’ (which EPA assumes is a
typographical error and is meant to
apply to furilazole).
This action establishes tolerances for
an inert ingredient used as a safener in
pesticide products; it is not relaxing
EPA standards or ignoring the potential
adverse effects of inert ingredients. Inert
ingredients are evaluated under the
same safety standard as active
ingredients under the FFDCA. Under
the existing legal framework provided
by FFDCA section 408, EPA is
authorized to establish pesticide
chemical tolerances or exemptions
where persons seeking such tolerances
or exemptions have demonstrated that
the pesticide chemical meets the safety
standard imposed by the statute. EPA
has evaluated the potential adverse
E:\FR\FM\03OCR1.SGM
03OCR1
52774
Federal Register / Vol. 84, No. 192 / Thursday, October 3, 2019 / Rules and Regulations
effects from exposure to this pesticide
chemical, taking into consideration data
on the potential for developmental
toxicity and carcinogenicity. No new
toxicity data were submitted in
connection with the present petition.
After evaluating the available data and
other information, EPA has determined
that the tolerances for this chemical are
safe. The commenters have provided no
other information for the Agency to
consider in making its safety
determination.
V. Conclusion
Based on available data, the Agency
concludes that tolerances for residues of
furilazole as discussed in this document
are safe. Accordingly, the Agency is
establishing tolerances for residues of
furilazole in or on corn, sweet, forage;
corn, sweet, kernel plus cob with husks
removed; and corn, sweet, stover at 0.01
ppm. In addition, EPA is revising the
tolerance expression to clarify that (1) as
provided in FFDCA section 408(a)(3),
the tolerance covers metabolites and
degradates of furilazole not specifically
mentioned and (2) compliance with the
specified tolerance levels is to be
determined by measuring only the
specific compounds mentioned in the
tolerance expression. EPA has
determined that it is reasonable to make
this change final without prior proposal
and opportunity for comment, because
public comment is not necessary, in that
the change has no substantive effect on
the tolerance, but rather is merely
intended to clarify the existing tolerance
expression.
VI. Statutory and Executive Order
Reviews
This action establishes tolerances
under FFDCA section 408(d) in
response to a petition submitted to the
Agency. The Office of Management and
Budget (OMB) has exempted these types
of actions from review under Executive
Order 12866, entitled ‘‘Regulatory
Planning and Review’’ (58 FR 51735,
October 4, 1993). Because this action
has been exempted from review under
Executive Order 12866, this action is
not subject to Executive Order 13211,
entitled ‘‘Actions Concerning
Regulations That Significantly Affect
Energy Supply, Distribution, or Use’’ (66
FR 28355, May 22, 2001) or Executive
Order 13045, entitled ‘‘Protection of
Children from Environmental Health
Risks and Safety Risks’’ (62 FR 19885,
April 23, 1997), nor is it considered a
regulatory action under Executive Order
13771, entitled ‘‘Reducing Regulations
and Controlling Regulatory Costs’’ (82
VerDate Sep<11>2014
16:33 Oct 02, 2019
Jkt 250001
FR 9339, February 3, 2017). This action
does not contain any information
collections subject to OMB approval
under the Paperwork Reduction Act
(PRA) (44 U.S.C. 3501 et seq.), nor does
it require any special considerations
under Executive Order 12898, entitled
‘‘Federal Actions to Address
Environmental Justice in Minority
Populations and Low-Income
Populations’’ (59 FR 7629, February 16,
1994).
Since tolerances and exemptions that
are established on the basis of a petition
under FFDCA section 408(d), such as
the tolerances in this final rule, do not
require the issuance of a proposed rule,
the requirements of the Regulatory
Flexibility Act (RFA) (5 U.S.C. 601 et
seq.), do not apply.
This action directly regulates growers,
food processors, food handlers, and food
retailers, not States or tribes, nor does
this action alter the relationships or
distribution of power and
responsibilities established by Congress
in the preemption provisions of FFDCA
section 408(n)(4). As such, the Agency
has determined that this action will not
have a substantial direct effect on States
or tribal governments, on the
relationship between the national
government and the States or tribal
governments, or on the distribution of
power and responsibilities among the
various levels of government or between
the Federal Government and Indian
tribes. Thus, the Agency has determined
that Executive Order 13132, entitled
‘‘Federalism’’ (64 FR 43255, August 10,
1999) and Executive Order 13175,
entitled ‘‘Consultation and Coordination
with Indian Tribal Governments’’ (65 FR
67249, November 9, 2000) do not apply
to this action. In addition, this action
does not impose any enforceable duty or
contain any unfunded mandate as
described under Title II of the Unfunded
Mandates Reform Act (UMRA) (2 U.S.C.
1501 et seq.). This action does not
involve any technical standards that
would require Agency consideration of
voluntary consensus standards pursuant
to section 12(d) of the National
Technology Transfer and Advancement
Act (NTTAA) (15 U.S.C. 272 note).
VII. Congressional Review Act
Pursuant to the Congressional Review
Act (5 U.S.C. 801 et seq.), EPA will
submit a report containing this rule and
other required information to the U.S.
Senate, the U.S. House of
Representatives, and the Comptroller
General of the United States prior to
publication of the rule in the Federal
PO 00000
Frm 00028
Fmt 4700
Sfmt 4700
Register. This action is not a ‘‘major
rule’’ as defined by 5 U.S.C. 804(2).
List of Subjects in 40 CFR Part 180
Environmental protection,
Administrative practice and procedure,
Agricultural commodities, Pesticides
and pests, Reporting and recordkeeping
requirements.
Dated: September 17, 2019.
Michael Goodis,
Director, Registration Division, Office of
Pesticide Programs.
Therefore, 40 CFR chapter I is
amended as follows:
PART 180—[AMENDED]
1. The authority citation for part 180
continues to read as follows:
■
Authority: 21 U.S.C. 321(q), 346a and 371.
■
2. In § 180.471(a):
■
a. Revise the introductory text; and
b. Add alphabetically the entries
‘‘Corn, sweet, forage’’; ‘‘Corn, sweet,
kernel plus cob with husks removed’’;
and ‘‘Corn, sweet, stover’’ to the table.
■
The revision and additions read as
follows:
§ 180.471 Furilazole; tolerances for
residues.
(a) General. Tolerances are
established for residues of furilazole,
including its metabolites and
degradates, when used as an inert
ingredient (safener) in pesticide
formulations applied to the following
raw agricultural commodities.
Compliance with the tolerance levels
specified in the table in this paragraph
(a) is to be determined by measuring
only furilazole, 3-dichloroacetyl-5-(2furanyl)-2, 2-dimethyloxazolidine (CAS
Reg. No. 121776–33–8) in or on the
commodity.
Parts per
million
Commodity
*
*
*
*
Corn, sweet, forage ....................
Corn, sweet, kernel plus cob
with husks removed ................
Corn, sweet, stover .....................
*
*
*
*
*
*
*
*
*
[FR Doc. 2019–20874 Filed 10–2–19; 8:45 am]
BILLING CODE 6560–50–P
E:\FR\FM\03OCR1.SGM
03OCR1
*
0.01
0.01
0.01
*
Agencies
[Federal Register Volume 84, Number 192 (Thursday, October 3, 2019)]
[Rules and Regulations]
[Pages 52771-52774]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-20874]
-----------------------------------------------------------------------
ENVIRONMENTAL PROTECTION AGENCY
40 CFR Part 180
[EPA-HQ-OPP-2018-0243; FRL-10000-23]
Furilazole; Pesticide Tolerances
AGENCY: Environmental Protection Agency (EPA).
ACTION: Final rule.
-----------------------------------------------------------------------
SUMMARY: This regulation establishes tolerances for residues of
furilazole in or on sweet corn commodities. The Monsanto Company
submitted a petition to EPA under the Federal Food, Drug, and Cosmetic
Act (FFDCA) requesting these tolerances.
DATES: This regulation is effective October 3, 2019. Objections and
requests for hearings must be received on or before December 2, 2019,
and must be filed in accordance with the instructions provided in 40
CFR part 178 (see also Unit I.C. of the SUPPLEMENTARY INFORMATION).
ADDRESSES: The docket for this action, identified by docket
identification (ID) number EPA-HQ-OPP-2018-0243, is available at https://www.regulations.gov or at the Office of Pesticide Programs Regulatory
Public Docket (OPP Docket) in the Environmental Protection Agency
Docket Center (EPA/DC), West William Jefferson Clinton Bldg., Rm. 3334,
1301 Constitution Ave. NW, Washington, DC 20460-0001. The Public
Reading Room is open from 8:30 a.m. to 4:30 p.m., Monday through
Friday, excluding legal holidays. The telephone number for the Public
Reading Room is (202) 566-1744, and the telephone number for the OPP
Docket is (703) 305-5805. Please review the visitor instructions and
additional information about the docket available at https://www.epa.gov/dockets.
FOR FURTHER INFORMATION CONTACT: Michael Goodis, Registration Division
(7505P), Office of Pesticide Programs, Environmental Protection Agency,
1200 Pennsylvania Ave. NW, Washington, DC 20460-0001; main telephone
number: (703) 305-7090; email address: [email protected].
SUPPLEMENTARY INFORMATION:
I. General Information
A. Does this action apply to me?
You may be potentially affected by this action if you are an
agricultural producer, food manufacturer, or pesticide manufacturer.
The following list of North American Industrial Classification System
(NAICS) codes is not intended to be exhaustive, but rather provides a
guide to help readers determine whether this document applies to them.
Potentially affected entities may include:
Crop production (NAICS code 111).
Animal production (NAICS code 112).
Food manufacturing (NAICS code 311).
Pesticide manufacturing (NAICS code 32532).
B. How can I get electronic access to other related information?
You may access a frequently updated electronic version of EPA's
tolerance regulations at 40 CFR part 180 through the Government
Publishing Office's e-CFR site at https://www.ecfr.gov/cgi-bin/text-idx?&c=ecfr&tpl=/ecfrbrowse/Title40/40tab_02.tpl.
C. How can I file an objection or hearing request?
Under FFDCA section 408(g), 21 U.S.C. 346a, any person may file an
objection to any aspect of this regulation and may also request a
hearing on those objections. You must file your objection or request a
hearing on this regulation in accordance with the instructions provided
in 40 CFR part 178. To ensure proper receipt by EPA, you must identify
docket ID number EPA-HQ-OPP-2018-0243 in the subject line on the first
page of your submission. All objections and requests for a hearing must
be in writing, and must be received by the Hearing Clerk on or before
December 2, 2019. Addresses for mail and hand delivery of objections
and hearing requests are provided in 40 CFR 178.25(b).
In addition to filing an objection or hearing request with the
Hearing Clerk as described in 40 CFR part 178, please submit a copy of
the filing (excluding any Confidential Business Information (CBI)) for
inclusion in the public docket. Information not marked confidential
pursuant to 40 CFR part 2 may be disclosed publicly by EPA without
prior notice. Submit the non-CBI copy of your objection or hearing
request, identified by docket ID number EPA-HQ-OPP-2018-0243, by one of
the following methods:
Federal eRulemaking Portal: https://www.regulations.gov.
Follow the online instructions for submitting comments. Do not submit
electronically any information you consider to be CBI or other
information whose disclosure is restricted by statute.
Mail: OPP Docket, Environmental Protection Agency Docket
Center (EPA/DC), (28221T), 1200 Pennsylvania Ave. NW, Washington, DC
20460-0001.
Hand Delivery: To make special arrangements for hand
delivery or delivery of boxed information, please follow the
instructions at https://www.epa.gov/dockets/contacts.html. Additional
instructions on commenting or visiting the docket, along with more
information about dockets generally, is available at https://www.epa.gov/dockets.
II. Summary of Petitioned-for Tolerance
In the Federal Register of October 18, 2018 (83 FR 52787) (FRL-
9984-21), EPA issued a document pursuant to FFDCA section 408(d)(3), 21
U.S.C. 346a(d)(3), announcing the filing of a pesticide petition (PP
IN-11139) by Monsanto, 1300 I Street NW, Washington, DC 20005. The
petition requested that 40 CFR part 180 be amended by establishing
tolerances for residues of furilazole when used as an inert ingredient
(safener) in pesticide formulations applied to corn, sweet, forage at
0.01 parts per million (ppm); corn, sweet, kernel plus cob with husks
removed at 0.01 ppm; and corn, sweet, stover at 0.01 ppm. That document
referenced a summary of the petition prepared by Monsanto, the
registrant, which is available in the docket, https://www.regulations.gov.
[[Page 52772]]
Based upon review of the data supporting the petition, EPA is
establishing the tolerances as requested.
III. Aggregate Risk Assessment and Determination of Safety
Section 408(b)(2)(A)(i) of FFDCA allows EPA to establish a
tolerance (the legal limit for a pesticide chemical residue in or on a
food) only if EPA determines that the tolerance is ``safe.'' Section
408(b)(2)(A)(ii) of FFDCA defines ``safe'' to mean that ``there is a
reasonable certainty that no harm will result from aggregate exposure
to the pesticide chemical residue, including all anticipated dietary
exposures and all other exposures for which there is reliable
information.'' This includes exposure through drinking water and in
residential settings but does not include occupational exposure.
Section 408(b)(2)(C) of FFDCA requires EPA to give special
consideration to exposure of infants and children to the pesticide
chemical residue in establishing a tolerance and to ``ensure that there
is a reasonable certainty that no harm will result to infants and
children from aggregate exposure to the pesticide chemical residue. . .
.''
Consistent with FFDCA section 408(b)(2)(D), and the factors
specified in FFDCA section 408(b)(2)(D), EPA has reviewed the available
scientific data and other relevant information in support of this
action. EPA has sufficient data to assess the hazards of and to make a
determination on aggregate exposure for furilazole including exposure
resulting from the tolerances established by this action. EPA's
assessment of exposures and risks associated with furilazole follows.
A. Toxicological Profile
EPA has evaluated the available toxicity data and considered their
validity, completeness, and reliability as well as the relationship of
the results of the studies to human risk. EPA has also considered
available information concerning the variability of the sensitivities
of major identifiable subgroups of consumers, including infants and
children. The toxicological profile of furilazole is discussed in the
final tolerance rule found in the Federal Register of October 10, 2007
(72 FR 57489) (FRL-8145-2). Specific information on the studies
received and the nature of the adverse effects caused by furilazole as
well as the no-observed-adverse-effect-level (NOAEL) and the lowest-
observed-adverse-effect-level (LOAEL) from the toxicity studies are
discussed in the final rule published in Unit III.A. of that Federal
Register document and in the supporting documents for that rule. In
addition, due to the similarities between that rule and this, EPA is
incorporating the findings concerning the children's safety factor and
cumulative exposure into this rule because they also apply to this
rulemaking. The summary of toxicological endpoints the Agency used to
assess risk are discussed in the final tolerance rule found in the
Federal Register of April 3, 2002 (67 FR 15727) (FRL-6828-4).
B. Exposure Assessment
1. Dietary exposure (food and drinking water). In evaluating
dietary exposure to furilazole, EPA considered exposure under the
proposed exemption from the requirement of a tolerance as well as the
already established tolerances for furilazole.
i. Acute exposure. Quantitative acute dietary exposure and risk
assessments are performed for a food-use pesticide, if a toxicological
study has indicated the possibility of an effect of concern occurring
as a result of a 1-day or single exposure.
No such effects were identified in the toxicological studies for
the general population for furilazole; therefore, a quantitative acute
dietary exposure assessment for the general population is unnecessary.
However, such effects were identified for furilazole for females 13
to 50 years old. In estimating acute dietary exposure, EPA used 2003-
2008 food consumption information from the U.S. Department of
Agriculture's National Health and Nutrition Examination Survey, What We
Eat in America, (NHANES/WWEIA). As to residue levels in food, EPA
conducted an unrefined acute dietary exposure and risk assessment
assuming 100 percent crop treated (PCT), default processing factors,
and tolerance-level residues for all food commodities.
ii. Chronic exposure. In conducting the chronic dietary exposure
assessment EPA used 2003-2008 food consumption data from the USDA's
NHANES/WWEIA. As to residue levels in food, EPA conducted an unrefined
chronic dietary exposure and risk assessment assuming 100 PCT, default
processing factors (when available), and tolerance level residues for
all food commodities.
iii. Cancer. As indicated in the 2002 Federal Register document,
EPA has concluded that furilazole should be classified as a possible
human carcinogen and a linear approach has been used the quantify
cancer risk since no mode of action data are available. The aggregate
cancer risk assessment for adults takes into account exposure estimates
from dietary consumption of furilazole from food and drinking water
sources. Dietary exposure assessments were quantified using the same
estimates as discussed in Unit III.B.1.ii, Chronic Exposure.
2. Dietary exposure from drinking water. The Agency used screening
level water exposure models in the dietary exposure analysis and risk
assessment for furilazole in drinking water. These simulation models
take into account data on the physical, chemical, and fate/transport
characteristics of furilazole. Further information regarding EPA
drinking water models used in pesticide exposure assessment can be
found at https://www2.epa.gov/pesticide-science-and-assessing-pesticide-risks/about-water-exposure-models-used-pesticide.
The estimated drinking water concentrations (EDWCs) of furilazole
for acute exposures are estimated to be 1.2 parts per billion (ppb) for
surface water and 0.02 ppb for ground water; for chronic exposures for
non-cancer assessments are estimated to be 0.8 ppb for surface water
and 0.02 ppb for ground water; and for chronic exposures for cancer
assessments are estimated to be 0.22 ppb for surface water and 0.02 ppb
for ground water.
Modeled estimates of drinking water concentrations were directly
entered into the dietary exposure model. For the acute dietary risk
assessment, a water concentration value of 1.2 ppb was used to assess
the contribution to drinking water, for the chronic dietary risk
assessment, the water concentration value of 0.8 ppb was used to assess
the contribution to drinking water. For the cancer dietary risk
assessment, the water concentration value of 0.22 ppb was used to
assess the contribution to drinking water.
3. From non-dietary exposure. The term ``residential exposure'' is
used in this document to refer to non-occupational, non-dietary
exposure (e.g., textiles (clothing and diapers), carpets, swimming
pools, and hard surface disinfection on walls, floors, tables). There
are no residential uses of furilazole; therefore, a residential
exposure assessment was not conducted.
4. Cumulative effects from substances with a common mechanism of
toxicity. Section 408(b)(2)(D)(v) of FFDCA requires that, when
considering whether to establish, modify, or revoke a tolerance, the
Agency consider ``available information'' concerning the cumulative
effects of a particular pesticide's residues and ``other substances
that have a common mechanism of toxicity.''
Unlike other pesticides for which EPA has followed a cumulative
risk approach
[[Page 52773]]
based on a common mechanism of toxicity, EPA has not made a common
mechanism of toxicity finding as to furilazole and any other
substances; furilazole does not appear to produce any other toxic
metabolite produced by other substances. For the purposes of this
action, therefore, EPA has not assumed that furilazole has a common
mechanism of toxicity with other substances.
C. Aggregate Risks and Determination of Safety
EPA determines whether acute and chronic dietary pesticide
exposures are safe by comparing aggregate exposure estimates to the
acute PAD (aPAD) and chronic PAD (cPAD). For linear cancer risks, EPA
calculates the lifetime probability of acquiring cancer given the
estimated aggregate exposure. Short-, intermediate-, and chronic-term
risks are evaluated by comparing the estimated aggregate food, water,
and residential exposure to the appropriate PODs to ensure that an
adequate MOE exists.
1. Acute risk. Using the exposure assumptions discussed in this
unit for acute exposure, the acute dietary exposure from food and water
to furilazole will be less than 1% for females 13 to 49 years old, the
only population group of concern.
2. Chronic risk. Using the exposure assumptions described in this
unit for chronic exposure, EPA has concluded that chronic exposure to
furilazole from food and water will utilize 13.3% of the cPAD for non-
nursing infants, the population group receiving the greatest exposure.
There are no expected residential uses and therefore chronic
residential exposure to residues of furilazole is not expected.
3. Short-term risk. Short-term aggregate exposure takes into
account short-term residential exposure plus chronic exposure to food
and water (considered to be a background exposure level). Because there
are no proposed or registered residential uses of furilazole a short-
term assessment was not performed. The chronic risk assessment is
protective for any short-term exposures from food and drinking water.
4. Intermediate-term risk. Intermediate-term aggregate exposure
takes into account intermediate-term residential exposure plus chronic
exposure to food and water (considered to be a background exposure
level). Because there are no proposed or registered residential uses of
furilazole an intermediate-term assessment was not performed. The
chronic risk assessment is protective for any intermediate-term
exposures from food and drinking water. Furilazole is not currently
registered for uses that could result in intermediate-term residential
exposure, and the Agency has determined that intermediate-term
aggregate exposure assessment is not necessary.
5. Aggregate cancer risk for U.S. population. A cancer aggregate
assessment was conducted for furilazole since it is classified as a
``Group C, Possible Human Carcinogen'' with a Q\1\* of 0.0274 (mg/kg/
day)-1 based upon hepatocellular ademonas and carcinomas in
rats and mice, branchioalveolar adenomas and carcinomas in female mice,
testicular interstitial cell interstitial cell tumors in male rats, and
stomach tumors in female mice. The cancer risk estimate for adults is
1.1 x 10-6.
EPA generally considers cancer risks (expressed as the probability
of an increased cancer case) in the range of 1 in 1 million (or 1 x
10-6) or less to be negligible. The precision which can be
assumed for cancer risk estimates is best described by rounding to the
nearest integral order of magnitude on the logarithmic scale; for
example, risks falling between 3 x 10-7 and 3 x
10-6 are expressed as risks in the range of 10-6.
Considering the precision with which cancer hazard can be estimated,
the conservativeness of low-dose linear extrapolation, and the rounding
procedure described above, cancer risk should generally not be assumed
to exceed the benchmark level of concern of the range of
10-6 until the calculated risk exceeds approximately 3 x
10-6. This is particularly the case where some conservatism
is maintained in the exposure assessment. EPA has concluded the cancer
risk for all existing furilazole uses and the uses associated with the
tolerances established in this action fall within the range of 1 x
10-6 and are thus negligible.
EPA has concluded that using the nonlinear approach based on the
chronic RfD will be protective of potential carcinogenicity.
Because the chronic risk is below the Agency's level of concern,
EPA concludes there is no aggregate cancer risk from exposure to
furilazole.
6. Determination of safety. Taking into consideration all available
information on furilazole, EPA has determined that there is a
reasonable certainty that no harm to any population subgroup will
result from aggregate exposure to furilazole.
IV. Other Considerations
A. Analytical Enforcement Methodology
Adequate enforcement methodology (capillary gas chromotography
using electron capture detection) is available to enforce the tolerance
exemption expression. The method may be requested from: Chief,
Analytical Chemistry Branch, Environmental Science Center, 701 Mapes
Rd., Ft. Meade, MD 20755-5350; telephone number: (410) 305-2905; email
address: [email protected].
B. International Residue Limits
In making its tolerance decisions, EPA seeks to harmonize U.S.
tolerances with international standards whenever possible, consistent
with U.S. food safety standards and agricultural practices. EPA
considers the international maximum residue limits (MRLs) established
by the Codex Alimentarius Commission (Codex), as required by FFDCA
section 408(b)(4). The Codex Alimentarius is a joint United Nations
Food and Agriculture Organization/World Health Organization food
standards program, and it is recognized as an international food safety
standards-setting organization in trade agreements to which the United
States is a party. EPA may establish a tolerance that is different from
a Codex MRL; however, FFDCA section 408(b)(4) requires that EPA explain
the reasons for departing from the Codex level. The Codex has not
established any MRLs for furilazole.
C. Response to Comments
Three comments were submitted to the docket for this action. One
dealt with ``relaxing'' current EPA standards; another argued that
inert ingredients should be regulated through tolerances. A third
comment took issue with data submitted about the toxicity of
``Florazole'' (which EPA assumes is a typographical error and is meant
to apply to furilazole).
This action establishes tolerances for an inert ingredient used as
a safener in pesticide products; it is not relaxing EPA standards or
ignoring the potential adverse effects of inert ingredients. Inert
ingredients are evaluated under the same safety standard as active
ingredients under the FFDCA. Under the existing legal framework
provided by FFDCA section 408, EPA is authorized to establish pesticide
chemical tolerances or exemptions where persons seeking such tolerances
or exemptions have demonstrated that the pesticide chemical meets the
safety standard imposed by the statute. EPA has evaluated the potential
adverse
[[Page 52774]]
effects from exposure to this pesticide chemical, taking into
consideration data on the potential for developmental toxicity and
carcinogenicity. No new toxicity data were submitted in connection with
the present petition. After evaluating the available data and other
information, EPA has determined that the tolerances for this chemical
are safe. The commenters have provided no other information for the
Agency to consider in making its safety determination.
V. Conclusion
Based on available data, the Agency concludes that tolerances for
residues of furilazole as discussed in this document are safe.
Accordingly, the Agency is establishing tolerances for residues of
furilazole in or on corn, sweet, forage; corn, sweet, kernel plus cob
with husks removed; and corn, sweet, stover at 0.01 ppm. In addition,
EPA is revising the tolerance expression to clarify that (1) as
provided in FFDCA section 408(a)(3), the tolerance covers metabolites
and degradates of furilazole not specifically mentioned and (2)
compliance with the specified tolerance levels is to be determined by
measuring only the specific compounds mentioned in the tolerance
expression. EPA has determined that it is reasonable to make this
change final without prior proposal and opportunity for comment,
because public comment is not necessary, in that the change has no
substantive effect on the tolerance, but rather is merely intended to
clarify the existing tolerance expression.
VI. Statutory and Executive Order Reviews
This action establishes tolerances under FFDCA section 408(d) in
response to a petition submitted to the Agency. The Office of
Management and Budget (OMB) has exempted these types of actions from
review under Executive Order 12866, entitled ``Regulatory Planning and
Review'' (58 FR 51735, October 4, 1993). Because this action has been
exempted from review under Executive Order 12866, this action is not
subject to Executive Order 13211, entitled ``Actions Concerning
Regulations That Significantly Affect Energy Supply, Distribution, or
Use'' (66 FR 28355, May 22, 2001) or Executive Order 13045, entitled
``Protection of Children from Environmental Health Risks and Safety
Risks'' (62 FR 19885, April 23, 1997), nor is it considered a
regulatory action under Executive Order 13771, entitled ``Reducing
Regulations and Controlling Regulatory Costs'' (82 FR 9339, February 3,
2017). This action does not contain any information collections subject
to OMB approval under the Paperwork Reduction Act (PRA) (44 U.S.C. 3501
et seq.), nor does it require any special considerations under
Executive Order 12898, entitled ``Federal Actions to Address
Environmental Justice in Minority Populations and Low-Income
Populations'' (59 FR 7629, February 16, 1994).
Since tolerances and exemptions that are established on the basis
of a petition under FFDCA section 408(d), such as the tolerances in
this final rule, do not require the issuance of a proposed rule, the
requirements of the Regulatory Flexibility Act (RFA) (5 U.S.C. 601 et
seq.), do not apply.
This action directly regulates growers, food processors, food
handlers, and food retailers, not States or tribes, nor does this
action alter the relationships or distribution of power and
responsibilities established by Congress in the preemption provisions
of FFDCA section 408(n)(4). As such, the Agency has determined that
this action will not have a substantial direct effect on States or
tribal governments, on the relationship between the national government
and the States or tribal governments, or on the distribution of power
and responsibilities among the various levels of government or between
the Federal Government and Indian tribes. Thus, the Agency has
determined that Executive Order 13132, entitled ``Federalism'' (64 FR
43255, August 10, 1999) and Executive Order 13175, entitled
``Consultation and Coordination with Indian Tribal Governments'' (65 FR
67249, November 9, 2000) do not apply to this action. In addition, this
action does not impose any enforceable duty or contain any unfunded
mandate as described under Title II of the Unfunded Mandates Reform Act
(UMRA) (2 U.S.C. 1501 et seq.). This action does not involve any
technical standards that would require Agency consideration of
voluntary consensus standards pursuant to section 12(d) of the National
Technology Transfer and Advancement Act (NTTAA) (15 U.S.C. 272 note).
VII. Congressional Review Act
Pursuant to the Congressional Review Act (5 U.S.C. 801 et seq.),
EPA will submit a report containing this rule and other required
information to the U.S. Senate, the U.S. House of Representatives, and
the Comptroller General of the United States prior to publication of
the rule in the Federal Register. This action is not a ``major rule''
as defined by 5 U.S.C. 804(2).
List of Subjects in 40 CFR Part 180
Environmental protection, Administrative practice and procedure,
Agricultural commodities, Pesticides and pests, Reporting and
recordkeeping requirements.
Dated: September 17, 2019.
Michael Goodis,
Director, Registration Division, Office of Pesticide Programs.
Therefore, 40 CFR chapter I is amended as follows:
PART 180--[AMENDED]
0
1. The authority citation for part 180 continues to read as follows:
Authority: 21 U.S.C. 321(q), 346a and 371.
0
2. In Sec. 180.471(a):
0
a. Revise the introductory text; and
0
b. Add alphabetically the entries ``Corn, sweet, forage''; ``Corn,
sweet, kernel plus cob with husks removed''; and ``Corn, sweet,
stover'' to the table.
The revision and additions read as follows:
Sec. 180.471 Furilazole; tolerances for residues.
(a) General. Tolerances are established for residues of furilazole,
including its metabolites and degradates, when used as an inert
ingredient (safener) in pesticide formulations applied to the following
raw agricultural commodities. Compliance with the tolerance levels
specified in the table in this paragraph (a) is to be determined by
measuring only furilazole, 3-dichloroacetyl-5-(2-furanyl)-2, 2-
dimethyloxazolidine (CAS Reg. No. 121776-33-8) in or on the commodity.
------------------------------------------------------------------------
Parts per
Commodity million
------------------------------------------------------------------------
* * * * *
Corn, sweet, forage......................................... 0.01
Corn, sweet, kernel plus cob with husks removed............. 0.01
Corn, sweet, stover......................................... 0.01
* * * * *
------------------------------------------------------------------------
* * * * *
[FR Doc. 2019-20874 Filed 10-2-19; 8:45 am]
BILLING CODE 6560-50-P